PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated ...
The State House Press Association's democratically selected top 10 stories of 2025 are: ...
Perhaps not surprisingly, the scientists found that, for every cognitively challenging activity performed one day a week, ...
In March 2025, only a few weeks into President Donald Trump’s second term, House Speaker Ron Mariano captured the sentiment ...
Stacker on MSN
Top science stories of 2025
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
The Paradox of the Scattered Genius Picture a typical day for a creative professional. Your morning starts with ten ideas at ...
Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...
In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...
ED boarding has become a widespread and chronic issue exacerbated by factors such as reduced inpatient capacity, staffing ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully integrated, commercial biotechnology company, announced today that Tonix management will present and host investor ...
How Putin, early in his presidency, tried to destroy Russia’s richest man. First published in 2003.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback